论文部分内容阅读
目的:探讨吸入性药物用于妊娠期支气管哮喘轻中度急性发作的效果。方法:将2014年2月至2016年2月在本院接受收治的70例妊娠期支气管哮喘轻中度急性发作患者随机分为A组和B组,每组35例。A、B两组患者均给予常规方法治疗,B组患者另给予地奈德混悬液雾化吸入治疗,观察比较两组患者的治疗效果。结果:B组患者的显效率、总有效率明显高于A组患者,比较差异均具有统计学意义(P<0.05),A、B两组患者治疗期间均未发生恶心、呕吐、声音嘶哑、皮疹等不良反应,患者生命体征稳定,胎心、胎动等情况无异常,组间比较差异无统计学意义(P>0.05)。结论:吸入性药物用于妊娠期支气管哮喘轻中度急性发作疗效显著,可以有效缓解哮喘症状,而且不良反应少,不会对孕妇和胎儿造成严重影响,安全可靠,具有极大的临床应用价值。
Objective: To investigate the effect of inhaled drugs on mild to moderate acute exacerbation of bronchial asthma during pregnancy. Methods: From February 2014 to February 2016, 70 patients with mild to moderate acute exacerbation of gestational bronchial asthma in our hospital were randomly divided into group A and group B, 35 cases in each group. Patients in group A and group B were treated by conventional method. Patients in group B were additionally treated with inhaled inhalation of desonide suspension. The therapeutic effect was compared between the two groups. Results: The effective rate and total effective rate of group B were significantly higher than that of group A (all P <0.05), and the patients in group A and B had no nausea, vomiting, hoarseness, Rash and other adverse reactions, patients with stable vital signs, fetal heart rate, fetal movement and other conditions were normal, there was no significant difference between the two groups (P> 0.05). Conclusions: Inhaled drugs are effective in mild to moderate acute exacerbation of bronchial asthma in pregnancy, which can effectively relieve the symptoms of asthma, and have few side effects and will not cause serious impact on pregnant women and fetus, so it is safe and reliable and has great clinical value .